Urinary biomarkers of chronic allograft nephropathy

Proteomics - Clinical Applications

Volumn 9, Issue 5-6, 2015, Pages 574-585

  Cassidy, Hilary ^a   Slyne, Jennifer ^a   O'Kelly, Patrick ^b   Traynor, Carol ^c   Conlon, Peter J ^b   Johnston, Olwyn ^d   Slattery, Craig ^a   Ryan, Michael P ^a   McMorrow, Tara ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Biomarkers; Chronic allograft nephropathy; Clusterin; NGAL; Renal transplantation

Indexed keywords

APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CLUSTERIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OROSOMUCOID; PEPTIDE FRAGMENT;

ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY TRANSPLANTATION; MASS SPECTROMETER; MASS SPECTROMETRY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; URINALYSIS; ALLOGRAFT; AMINO ACID SEQUENCE; CHEMISTRY; DELAYED GRAFT FUNCTION; GRAFT REJECTION; KIDNEY DISEASE; MOLECULAR GENETICS; PROTEINURIA; URINE;

ALLOGRAFTS; AMINO ACID SEQUENCE; BIOMARKERS; DELAYED GRAFT FUNCTION; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEINURIA;

EID: 84930897482     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400200     Document Type: Article

References (73)

1. Johnston, O., Cassidy, H., O'Connell, S., O'Riordan, A. et al., Identification of beta2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods. Proteomics Clin. Appl. 2011, 5, 422-431.
2. Slattery, C., Cassidy, H., Johnston, O., Ryan, M. P., McMorrow, T., Mechanisms of Calcineurin Inhibitor Nephrotoxicity in Chronic Allograft Injury, InTech, India, 2012, 191-212.
3. Bergmann, L., Roper, L., Bow, L. M., Hull, D. et al., Late graft loss in cadaveric renal transplantation. Transplant Proc. 1992, 24, 2718-2719.
4. Paul, L. C., Chronic allograft nephropathy: An update. Kidney Int. 1999, 56, 783-793.
5. Weir, M. R., Wali, R. K., Minimizing the risk of chronic allograft nephropathy. Transplantation 2009, 87, S14-S18.
6. Andoh, T. F., Bennett, W. M., Chronic cyclosporine nephrotoxicity. Curr. Opin. Nephrol. Hypertens 1998, 7, 265-270.
7. El-Zoghby, Z. M., Stegall, M. D., Lager, D. J., Kremers, W. K. et al., Identifying specific causes of kidney allograft loss. Am. J. Transplant 2009, 9, 527-535.
8. Cassidy, H., Slyne, J., Frain, H., Slattery, C. et al., High-throughput proteomic approaches to the elucidation of potential biomarkers of chronic allograft injury (CAI). Proteomes 2013, 1, 159-179.
9. Meier-Kriesche, H. U., Schold, J. D., Srinivas, T. R., Kaplan, B., Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant 2004, 4, 378-383.
10. de Fijter, J. W., Rejection and function and chronic allograft dysfunction. Kidney Int. Suppl. 2010, S38-S41.
11. Solez, K., Colvin, R. B., Racusen, L. C., Sis, B. et al., Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am. J. Transplant 2007, 7, 518-526.
12. Sijpkens, Y. W., Doxiadis, II, vanKemenade, F. J., Zwinderman, A. H. et al., Chronic rejection with or without transplant vasculopathy. Clin. Transplant 2003, 17, 163-170.
13. Cosio, F. G., Alamir, A., Yim, S., Pesavento, T. E. et al., Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int. 1998, 53, 767-772.
14. Hariharan, S., McBride, M. A., Cherikh, W. S., Tolleris, C. B. et al., Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 2002, 62, 311-318.
15. Nankivell, B. J., Borrows, R. J., Fung, C. L., O'Connell, P. J. et al., Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004, 78, 242-249.
16. Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M. et al., The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999, 55, 713-723.
17. Afzali, B., Taylor, A. L., Goldsmith, D. J., What we CAN do about chronic allograft nephropathy: role of immunosuppressive modulations. Kidney Int. 2005, 68, 2429-2443.
18. Sarwal, M., Chua, M. S., Kambham, N., Hsieh, S. C. et al., Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 2003, 349, 125-138.
19. Wilczek, H. E., Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies. Transplantation 1990, 50, 790-797.
20. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
21. Akalin, E., O'Connell, P. J., Genomics of chronic allograft injury. Kidney Int. Suppl. 2010, S33-S37.
22. Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O. et al., Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 1999, 341, 1725-1730.
23. Nankivell, B. J., Borrows, R. J., Fung, C. L., O'Connell, P. J. et al., The natural history of chronic allograft nephropathy. N. Engl. J. Med. 2003, 349, 2326-2333.
24. Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N., Cosimi, A. B., Strategies to improve long-term outcomes after renal transplantation. N. Engl. J. Med. 2002, 346, 580-590.
25. Clarke, W., Silverman, B. C., Zhang, Z., Chan, D. W. et al., Characterization of renal allograft rejection by urinary proteomic analysis. Ann. Surg. 2003, 237, 660-664; discussion 664-665.
26. O'Riordan, E., Orlova, T. N., Mei, J. J., Butt, K. et al., Bioinformatic analysis of the urine proteome of acute allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 3240-3248.
27. Schaub, S., Rush, D., Wilkins, J., Gibson, I. W. et al., Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 219-227.
28. Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O. et al., Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant 2005, 5, 729-738.
29. Camara, N. O., Williams, W. W., Jr., Pacheco-Silva, A., Proximal tubular dysfunction as an indicator of chronic graft dysfunction. Braz J. Med. Biol. Res. 2009, 42, 229-236.
30. Zhou, S. T., Yan, J. H., Yang, C., Zeng, N. et al., [Construction of protein fingerprint signature in serum and its significance for early diagnosis with chronic allograft nephropathy]. Zhonghua Yi Xue Za Zhi 2006, 86, 1966-1969.
31. Banon-Maneus, E., Diekmann, F., Carrascal, M., Quintana, L. F. et al., Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers. Transplantation 2010, 89, 548-558.
32. Plesner, T., Bjerrum, O. J., Distribution of 'free' and HLA-associated human beta 2-microglobulin in some plasma membranes and biological fluids. Scand. J. Immunol. 1980, 11, 341-351.
33. Schardijn, G. H., Statius van Eps, L. W., Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney Int. 1987, 32, 635-641.
34. Woo, K. T., Lee, E. J., Lau, Y. K., Lim, C. H., Beta-2-microglobulin in the assessment of renal function of the transplanted kidney. Nephron 1985, 39, 223-227.
35. Sumboonnanonda, A., Malasit, P., Tanphaichitr, V. S., Ong-ajyooth, S. et al., Renal tubular dysfunction in alpha-thalassemia. Pediatr. Nephrol. 2003, 18, 257-260.
36. Bernard, A., Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 2004, 17, 519-523.
37. Trougakos, I. P., Gonos, E. S., Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem, Cell Biol. 2002, 34, 1430-1448.
38. Calero, M., Rostagno, A., Frangione, B., Ghiso, J., Clusterin and Alzheimer's disease. Subcell Biochem. 2005, 38, 273-298.
39. Trougakos, I. P., Gonos, E. S., Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals. Adv. Cancer Res. 2009, 104, 171-210.
40. Pucci, S., Bonanno, E., Pichiorri, F., Angeloni, C., Spagnoli, L. G., Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 2004, 23, 2298-2304.
41. Michel, D., Chatelain, G., North, S., Brun, G., Stress-induced transcription of the clusterin/apoJ gene. Biochem. J. 1997, 328(Pt 1), 45-50.
42. Wilson, M. R., Easterbrook-Smith, S. B., Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 2000, 25, 95-98.
43. Huang, Q., Dunn, R. T., 2nd, Jayadev, S., DiSorbo, O. et al., Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol. Sci. 2001, 63, 196-207.
44. Ishii, A., Sakai, Y., Nakamura, A., Molecular pathological evaluation of clusterin in a rat model of unilateral ureteral obstruction as a possible biomarker of nephrotoxicity. Toxicol. Pathol. 2007, 35, 376-382.
45. Dieterle, F., Perentes, E., Cordier, A., Roth, D. R. et al., Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat. Biotechnol. 2010, 28, 463-469.
46. Girton, R. A., Sundin, D. P., Rosenberg, M. E., Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity. Am. J. Physiol. Renal. Physiol. 2002, 282, F703-F709.
47. Jung, G. S., Kim, M. K., Jung, Y. A., Kim, H. S. et al., Clusterin attenuates the development of renal fibrosis. J. Am. Soc. Nephrol. 2012, 23, 73-85.
48. Zhou, W., Guan, Q., Kwan, C. C., Chen, H. et al., Loss of clusterin expression worsens renal ischemia-reperfusion injury. Am. J. Physiol. Renal. Physiol 2010, 298, F568-F578.
49. Ichimura, T., Bonventre, J. V., Bailly, V., Wei, H. et al., Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 1998, 273, 4135-4142.
50. Bailly, V., Zhang, Z., Meier, W., Cate, R. et al., Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. 2002, 277, 39739-39748.
51. Han, W. K., Bailly, V., Abichandani, R., Thadhani, R., Bonventre, J. V., Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002, 62, 237-244.
52. Smyth, M. J., Dual mechanisms of lymphocyte-mediated cytotoxicity serve to control and deliver the immune response. Bioessays 1995, 17, 891-898.
53. Vaidya, V. S., Ramirez, V., Ichimura, T., Bobadilla, N. A., Bonventre, J. V., Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal Physiol. 2006, 290, F517-F529.
54. Zhang, P. L., Rothblum, L. I., Han, W. K., Blasick, T. M. et al., Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int. 2008, 73, 608-614.
55. Kewalramani, R., Ichimura, T., Bonventre, J., Sayegh, M., Chandraker, A., Kidney Injury Molecule expression in acute and chronic rejection: Novel Application of a novel molecule. Am. J. Transplant 2003, May, 398.
56. Vella, J., Harris, S., Garrison, K., McGoldrick, M. et al., Transcripts for kidney injury molecule-1 (KIM-1) are specific biomarkers predicting delayed graft function in kidney transplantation. Transplantation 2006, 15, 398.
57. Szeto, C. C., Kwan, B. C., Lai, K. B., Lai, F. M. et al., Urinary expression of kidney injury markers in renal transplant recipients. Clin J. Am. Soc. Nephrol. 2010, 5, 2329-2337.
58. Ting, Y. T., Coates, P. T., Walker, R. J., McLellan, A. D., Urinary tubular biomarkers as potential early predictors of renal allograft rejection. Nephrology (Carlton) 2012, 17, 11-16.
59. Akerstrom, B., Flower, D., Salier, J., Lipocalins: unity in diversity. Biochem. Biophys. Acta 2000, 1-8.
60. Borregaard, N., Cowland, J. B., Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals 2006, 19, 211-215.
61. Kuwabara, T., Mori, K., Mukoyama, M., Kasahara, M. et al., Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009, 75, 285-294.
62. Mishra, J., Ma, Q., Prada, A., Mitsnefes, M. et al., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 2003, 14, 2534-2543.
63. Bonventre, J. V., Yang, L., Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 2011, 121, 4210-4221.
64. Schaub, S., Mayr, M., Honger, G., Bestland, J. et al., Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation 2007, 84, 104-112.
65. Malyszko, J., Malyszko, J. S., Bachorzewska-Gajewska, H., Poniatowski, B. et al., Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc. 2009, 41, 158-161.
66. Mishra, J., Mori, K., Ma, Q., Kelly, C. et al., Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 2004, 15, 3073-3082.
67. Myers, B. D., Ross, J., Newton, L., Luetscher, J., Perlroth, M., Cyclosporine-associated chronic nephropathy. N. Engl. J. Med. 1984, 311, 699-705.
68. Wasilewska, A., Taranta-Janusz, K., Debek, W., Zoch-Zwierz, W., Kuroczycka-Saniutycz, E., KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr. Nephrol. 2011, 26, 579-586.
69. Hollmen, M. E., Kyllonen, L. E., Inkinen, K. A., Lalla, M. L., Salmela, K. T., Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int. 2011, 79, 89-98.
70. Port, F. K., Bragg-Gresham, J. L., Metzger, R. A., Dykstra, D. M. et al., Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002, 74, 1281-1286.
71. Devarajan, P., Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther. 2007, 5, 463-470.
72. Hollmen, M. E., Kyllonen, L. E., Inkinen, K. A., Lalla, M. L. et al., Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Crit. Care 2011, 15, R121.
73. Womer, K. L., Sayegh, M. H., Late Allograft Dysfunction : An Ongoing Problem in Kidney Transplantation. Nephrology Rounds 2005, 3.